Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 15,217 | 12,715 | 17,418 | 17,635 | 14,774 |
| Cost of Goods | 2,475 | 2,146 | 2,391 | 2,011 | 1,708 |
| Gross Profit | 12,742 | 10,569 | 15,027 | 15,624 | 13,066 |
| Operating Expenses | 17,118 | 11,360 | 14,382 | 13,022 | 9,345 |
| Operating Income | -3,901 | -645 | 1,036 | 2,613 | 4,429 |
| Interest Expense | 706 | 769 | 764 | 766 | 1,088 |
| Other Income | 18 | 38 | 298 | 280 | 2,508 |
| Pre-tax Income | -4,589 | -1,376 | 570 | 2,127 | 5,849 |
| Net Income Continuous | -4,589 | -1,376 | 570 | 2,055 | 5,849 |
| Net Income | $-4,589 | $-1,376 | $570 | $2,055 | $5,849 |
| EPS Basic Total Ops | -0.23 | -0.08 | 0.03 | 2.19 | 0.43 |
| EPS Basic Continuous Ops | -0.23 | -0.08 | 0.03 | 1.45 | 0.46 |
| EPS Diluted Total Ops | -0.23 | -0.08 | 0.03 | 2.01 | 0.05 |
| EPS Diluted Continuous Ops | -0.23 | -0.08 | 0.03 | 1.50 | 0.41 |
| EBITDA(a) | $-3,568 | $-315 | $1,351 | $2,947 | $4,961 |